REFERENCES
- Karakaya K, Ucan HB, Tascilar O, Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration. J Invest Surg. 2009;22:201–206.
- Kurt M, Akdogan M, Onal IK, Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2009 in press.
- Kurt M, Disibeyaz S, Akdogan M, Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report. Am J Gastroenterol. 2008;103:2156–2158.
- Turhan N, Kurt M, Shorbagi A, Topical ankaferd blood stopper administration to bleeding gastrointestinal carcinomas decreases tumor vascularization. Am J Gastroenterol. 2009 in press.
- Ibis M, Kurt M, Onal IK, Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd blood stopper. J Altern Complement Med. 2008;14:1073–1074.
- Kurt M, Oztas E, Kuran S, Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med. 2009;27:631.
- Kurt M, Kacar S, Onal IK, Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008;40(Suppl 2):E262.